My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Artson Engineering gets revision in ratings of bank facilities
Jun 28,2017

Artson Engineering announced that India Rating and Research has revised the following rating to the bank facilities of the Company -

Fund based working capital limits - IND AA-(SO)/ Stable / IND A1+(SO)
Non fund based limits - IND AA-(SO) / Stable / IND A1+ (SO)
Term loan - IND AA- (SO) / Stable

Powered by Capital Market - Live News

Sportking India gets upgradation in credit ratings
Jun 28,2017

Sportking India announced that ICRA has upgraded the Bank loan rating of the Company as under -

Long term debts - ICRA BBB+ (Revised from ICRA BBB)
Short term debts - ICRA A2 (Revised from ICRA A3+)

Powered by Capital Market - Live News

Shantai Industries fixes record date for bonus issue
Jun 28,2017

Shantai Industries has fixed 07 July 2017 as record date for bonus issue.

Powered by Capital Market - Live News

Vimta Labs reverses recent rally
Jun 28,2017

Meanwhile, the S&P BSE Sensex was down 125.79 points, or 0.41% at 30,832.46. The S&P BSE Small-Cap index was up 18.40 points, or 0.12% at 15,159.48.

On the BSE, 29,000 shares were traded on the counter so far as against the average daily volumes of 46,598 shares in the past one quarter. The stock had hit a high of Rs 142 and a low of Rs 137.20 so far during the day. The stock had hit a 52-week high of Rs 153.90 on 27 June 2017. The stock had hit a 52-week low of Rs 68.75 on 28 June 2016.

The stock had outperformed the market over the past one month till 27 June 2017, rising 18.83% compared with 0.23% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 30.1% as against Sensexs 5.89% rise. The scrip had also outperformed the market in past one year, surging 102.22% as against Sensexs 17.25% rise.

The small-cap company has equity capital of Rs 4.42 crore. Face value per share is Rs 2.

Vimta Labs net profit rose 32.6% to Rs 2.40 crore on 19.9% increase in net sales to Rs 39.47 crore in Q4 March 2017 over Q4 March 2016.

Vimta Labs is engaged in the business of contract research and testing services. The company provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.

Powered by Capital Market - Live News

Indiabulls Real Estate garners 7.92% in three sessions
Jun 28,2017

The announcement was made after market hours yesterday, 27 June 2017.

The stock has gained 7.92% in three sessions to its ruling price from a close of Rs 191.80 on 22 June 2017.

Meanwhile, the S&P BSE Sensex was down 139.54 points or 0.45% at 30,818.71. The S&P BSE Mid-Cap index was up 21.61 points or 0.15% at 14,490.49.

On the BSE, 16.99 lakh shares were traded on the counter so far as against the average daily volumes of 39.9 lakh shares in the past one quarter. The stock had hit a high of Rs 209.60 and a low of Rs 204.25 so far during the day. The stock had hit a 52-week high of Rs 217.40 on 21 June 2017 and a 52-week low of Rs 57.05 on 22 November 2016.

The stock had outperformed the market over the past one month till 27 June 2017, gaining 26.38% compared with 0.23% fall in the Sensex. The scrip had also outperformed the market in past one quarter, jumping 152.29% as against Sensexs 5.89% rise. The scrip had also outperformed the market in past one year, surging 131.87% as against Sensexs 17.25% rise.

The mid-cap company has equity capital of Rs 94.93 crore. Face value per share is Rs 2.

Indiabulls Real Estate has acquired the entire minority stake of 10.08% in Indiabulls Infraestate (IIL), a majority owned material subsidiary of the company, from ILFS Fund entities namely IIRF India Realty XXI, Little Fairy and Vistra ITCL (India), its minority investors.

The aggregate cash consideration paid for the acquisition is Rs 358.44 crore, including interest of Rs 94.85 crore against their aggregate total investment of Rs 250 crore. With this acquisition, IIL has become a wholly owned subsidiary of the company. IIL is developing a premium integrated marque residential project Indiabulls Blu in Worli, Mumbai comprising of 4 residential towers and additionally 2 office towers in the non residential area.

On consolidated basis, Indiabulls Real Estates net profit fell 3.7% to Rs 60.18 crore on 38.4% decline in net sales to Rs 437.03 crore in Q4 March 2017 over Q4 March 2016.

Indiabulls Real Estate is a real estate development company with development projects spread across office and commercial complexes, premium residential developments, mega townships, retail spaces, hotel and resorts, special economic zones and infrastructure development.

Powered by Capital Market - Live News

Maruti Suzuki India inches up after brokerage upgrade
Jun 28,2017

Meanwhile, the S&P BSE Sensex was down 112.65 points, or 0.36% to 30,845.61

On the BSE, 36,000 shares were traded in the counter so far, compared with average daily volumes of 60,622 shares in the past one quarter. The stock had hit a high of Rs 7,322.45 and a low of Rs 7,207 so far during the day. The stock hit a record high of Rs 7,469 on 9 June 2017. The stock hit a 52-week low of Rs 4,008 on 27 June 2016.

The stock had outperformed the market over the past one month till 27 June 2017, rising 0.81% compared with 0.23% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 21.05% as against Sensexs 5.89% rise. The scrip had also outperformed the market in past one year, surging 76.53% as against Sensexs 17.25% rise.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

A foreign brokerage house reportedly retained its buy call on Maruti Suzuki India and raised target price on the stock to Rs 8,824 from Rs 7,412 earlier. The stock will continue to trade at premium valuations due to high growth visibility and consistently improving free cash flow due to limited capex requirements, the brokerage house said.

Maruti Suzuki Indias net profit rose 15.8% to Rs 1709 crore on 20.3% growth in net sales to Rs 18005.20 crore in Q4 March 2017 over Q4 March 2016.

Maruti Suzuki India is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation currently holds 56.21% stake in Maruti Suzuki India (as per the shareholding pattern as on 31 March 2017).

Powered by Capital Market - Live News

Indian Hume Pipe advances on bargain hunting
Jun 28,2017

Meanwhile, the S&P BSE Sensex was down 107.48 points, or 0.35% at 30,850.77. The S&P BSE Small-Cap index was up 24.40 points, or 0.16% at 15,165.48.

On the BSE, 7,417 shares were traded on the counter so far as against the average daily volumes of 13,083 shares in the past one quarter. The stock had hit a high of Rs 506.75 and a low of Rs 479.75 so far during the day. The stock had hit a record high of Rs 546.50 on 20 June 2017 and a 52-week low of Rs 162.55 on 27 June 2016.

The stock had outperformed the market over the past one month till 27 June 2017, advancing 14.72% compared with the Sensexs 0.23% fall. The scrip had also outperformed the market over the past one quarter gaining 31.02% as against the Sensexs 5.89% rise. The scrip had also outperformed the market over the past one year advancing 181.39% as against the Sensexs 17.25% rise.

The small-cap company has equity capital of Rs 9.69 crore. Face value per share is Rs 2.

Shares of Indian Hume Pipe Company had declined 7.72% in the preceding four trading sessions to settle at Rs 485.90 yesterday, 27 June 2017, from its closing price of Rs 526.55 on 20 June 2017.

Shares of Indian Hume Pipe Company turned ex-dividend today, 28 June 2017, for final dividend of Rs 2.40 per share for the financial year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.49% based on the closing price of Rs 485.90 yesterday, 27 June 2017.

Indian Hume Pipe Companys net profit spurted 252.5% to Rs 33.24 crore on 64% increase in net sales to Rs 488.01 crore in Q4 March 2017 over Q4 March 2016.

Indian Hume Pipe Company is engaged in the business of providing integrated water supply schemes including manufacturing, laying and jointing of pipelines of various pipe materials which provide infrastructure facility for development of water supply and irrigation projects.

Powered by Capital Market - Live News

Fortis Healthcare gets healthier after buzz of listing diagnostics arm
Jun 28,2017

Meanwhile, the S&P BSE Sensex was down 93.57 points, or 0.3%, to 30,864.68. The S&P BSE Mid-Cap index was up 38.07 points, or 0.26%, to 14,506.95.

On the BSE, 5.35 lakh shares were traded in the counter so far, compared with an average volume of 9.39 lakh shares in the past one quarter. The stock had hit a high of Rs 171.85 and a low of Rs 166.75 so far during the day.

The stock had hit a record high of Rs 230.90 on 3 May 2017. The stock had hit a 52-week low of Rs 142.60 on 9 November 2016.

The stock had underperformed the market over the past one month till 27 June 2017, falling 18.59% compared with 0.23% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 7.17% as against Sensexs 5.89% rise. The scrip had also underperformed the market in past one year, gaining 5.7% as against Sensexs 17.25% rise.

The mid-cap company has an equity capital of Rs 518.46 crore. Face value per share is Rs 10.

A news agency reported that as a part of its scheme of demerger from their parent Fortis Healthcare, diagnostic chain, SRL Diagnostics (SRL) is likely to be listed on Indian bourses by August.

According to reports, the next hearing on the demerger plan in the National Company Law Tribunal (NCLT) has been scheduled for 29 June 2017, after five hearings till date.

Brothers Shivinder and Malvinder Singh, promoter of the company initiated a major corporate restructuring in August 2016.

SRL was spun off from Fortis to merge into its existing listed subsidiary Fortis Malar Hospitals and was renamed SRL Diagnostics.

The stock had dropped 16.62% in two sessions to Rs 165.05 yesterday, 27 June 2017 from a close of Rs 197.95 on 22 June 2017 triggered by reports suggesting IHH Healthcare Berhad is not close to concluding any negotiations to buy controlling stake in the company. Earlier reports had suggested that IHH Healthcare Bhd will be buying a controlling stake in Fortis Healthcare and SRL Logistics from Malvinder and Shivinder Mohan Singh, the promoters of the company.

With regards to news titled n++HH Pulls Plug on Fortis Deal Over Daiichi Scaren++, the company clarified during market hours on 23 June 2017 that the company is still evaluating possible way to raise fund and no firm decision in the regard has been approved by the board till date.

Fortis Healthcare reported consolidated net loss of Rs 37.52 crore in Q4 March 2017 compared with net loss of Rs 87.6 crore in Q4 March 2016. Net sales rose 5% to Rs 1123.43 crore in Q4 March 2017 over Q4 March 2016.

Fortis Healthcare is a leading integrated healthcare delivery service provider in India.

Powered by Capital Market - Live News

3i Infotech jumps after prepaying debt
Jun 28,2017

The announcement was made during market hours today, 28 June 2017.

Meanwhile, the S&P BSE Sensex was down 156.62 points, or 0.51%, to 30,801.63. The S&P BSE Small-Cap index was down 10.42 points, or 0.07%, to 15,130.66.

Huge volumes were witnessed on the counter. On the BSE, 9.89 lakh shares were traded in the counter so far, compared with average daily volume of 4.98 lakh shares in the past one quarter. The stock had hit a high of Rs 4.75 in intraday trade. The stock had hit a low of Rs 4.02 so far during the day, which is also a 52-week low for the stock. The stock had hit a 52-week high of Rs 7.20 on 24 October 2016.

The stock had dropped 7.88% in six sessions to Rs 4.09 yesterday, 27 June 2017, from a close of Rs 4.44 on 16 June 2017.

The stock had underperformed the market over the past one month till 27 June 2017, falling 14.79% compared with 0.23% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 20.43% as against Sensexs 5.89% rise. The scrip had also underperformed the market in past one year, dropping 14.08% as against Sensexs 17.25% rise.

The small-cap company has an equity capital of Rs 1245.98 crore. Face value per share is Rs 10.

3i Infotech said that the amount represents 6 monthly installments of the principal amount which were due for repayment from 30 April 2018 as per the terms of the Debt Realignment Scheme (DRS) approved by its lenders.

The company continues to service its lenders on a regular basis from the effective date of implementation of DRS from 1 April 2016.

3i Infotechs consolidated net profit rose 75.38% to Rs 33.34 crore on 3.03% rise in net sales to Rs 255.52 crore in Q4 March 2017 over Q3 December 2016.

3i Infotech provides software solutions and a wide range of IT services.

Powered by Capital Market - Live News

Board of Nectar Lifescience recommends final dividend
Jun 28,2017

Nectar Lifescience announced that the Board of Directors of the Company at its meeting held on 27 June 2017, inter alia, have recommended the final dividend of Rs 0.05 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Jiya Eco-Products to hold board meeting
Jun 28,2017

Jiya Eco-Products will hold a meeting of the Board of Directors of the Company on 4 July 2017.

Powered by Capital Market - Live News

RPG Life Sciences to hold AGM
Jun 28,2017

RPG Life Sciences announced that the 10th Annual General Meeting (AGM) of the company will be held on 24 July 2017.

Powered by Capital Market - Live News

Shoppers Stop to hold AGM
Jun 28,2017

Shoppers Stop announced that the 29th Annual General Meeting (AGM) of the company will be held on 28 July 2017.

Powered by Capital Market - Live News

Kalyani Investment Company to hold AGM
Jun 28,2017

Kalyani Investment Company announced that the 8th Annual General Meeting (AGM) of the company will be held on 1 August 2017.

Powered by Capital Market - Live News

GIC Housing Finance to hold board meeting
Jun 28,2017

GIC Housing Finance will hold a meeting of the Board of Directors of the Company on 24 July 2017, to consider amongst other things, to approve and take on record the Un-audited (provisional) Financial Results for the first quarter ended 30th June, 2017.

Powered by Capital Market - Live News